tiprankstipranks
Trending News
More News >
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
US Market
Advertisement

Citius Pharmaceuticals (CTXR) Technical Analysis

Compare
1,723 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
4Neutral
10Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Citius Pharmaceuticals’s (CTXR) Moving Averages Convergence Divergence (MACD) indicator is 0.13, suggesting Citius Pharmaceuticals is a Buy.
Citius Pharmaceuticals’s (CTXR) 20-Day exponential moving average is 1.54, while Citius Pharmaceuticals’s (CTXR) share price is $1.53, making it a Sell.
Citius Pharmaceuticals’s (CTXR) 50-Day exponential moving average is 1.35, while Citius Pharmaceuticals’s (CTXR) share price is $1.53, making it a Buy.

Citius Pharmaceuticals (CTXR) Pivot Points

Jul 20, 2025, 05:15 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.38
1.44
1.52
1.58
1.66
1.72
1.80
Fibonacci
1.44
1.49
1.53
1.58
1.63
1.67
1.72
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Citius Pharmaceuticals (CTXR) Moving Averages

Jul 20, 2025, 05:15 AM
Period
Simple
Exponential
MA5
1.58Sell
1.58Sell
MA10
1.69Sell
1.62Sell
MA20
1.61Sell
1.54Sell
MA50
1.14Buy
1.35Buy
MA100
1.19Buy
1.92Sell
MA200
3.34Sell
4.86Sell
Citius Pharmaceuticals’s (CTXR) 10-Day exponential moving average is 1.62, while Citius Pharmaceuticals’s (CTXR) share price is $1.53, making it a Sell.
Citius Pharmaceuticals’s (CTXR) 100-Day exponential moving average is 1.92, while Citius Pharmaceuticals’s (CTXR) share price is $1.53, making it a Sell.
Citius Pharmaceuticals’s (CTXR) stock price is $1.53 and Citius Pharmaceuticals’s (CTXR) 50-day simple moving average is 1.14, creating a Buy signal.
Citius Pharmaceuticals’s (CTXR) stock price is $1.53 and Citius Pharmaceuticals’s (CTXR) 100-day simple moving average is 1.19, creating a Buy signal.
Citius Pharmaceuticals’s (CTXR) stock price is $1.53 and Citius Pharmaceuticals’s (CTXR) 200-day simple moving average is 3.34, creating a Sell signal.

Citius Pharmaceuticals (CTXR) Technical Indicators

Jul 20, 2025, 05:15 AM
Name
Value
Implied Action
RSI (14)
51.99
Neutral
STOCH (9,6)
14.68
Buy
STOCHRSI (14)
19.48
Buy
MACD (12,26)
0.13
Buy
ADX (14)
49.76
Neutral
Williams %R
-89.62
Buy
CCI (14)
-11.22
Neutral
ATR (14)
0.23
-
Ultimate Oscillator
38.99
Neutral
ROC
0.00
Buy
Citius Pharmaceuticals’s (CTXR) Relative Strength Index (RSI) is 51.99, creating a Neutral signal.
Citius Pharmaceuticals’s (CTXR) Trend Strength Indicator (ADX) is 49.76, creating a Neutral signal.
Citius Pharmaceuticals’s (CTXR) Commodity Channel Index (CCI) is -11.22, creating a Neutral signal.

FAQ

Is CTXR a Buy, Hold, or Sell?
Based on CTXR’s technical indicators, CTXR is a Sell.
    What is CTXR’s RSI (14)?
    CTXR’s RSI (14) is 51.99, which suggests CTXR is a Neutral.
      What is CTXR’s MACD?
      CTXR’s MACD is 0.13, which suggests CTXR is a Buy.
        What is CTXR’s 5-day moving average?
        CTXR’s 5-day moving average is 1.58, which suggests CTXR is a Sell.
          What is CTXR’s 20-day moving average?
          CTXR 20-day moving average is 1.61, which suggests CTXR is a Sell.
            What is CTXR’s 50-day moving average?
            CTXR’s 50-day moving average is 1.14, which suggests CTXR is a Buy.
              What is CTXR’s 200-day moving average?
              CTXR’s 200-day moving average is 3.34, which suggests CTXR is a Sell.
                What is CTXR’s Williams % R (14)?
                CTXR’s Williams % R (14) is -89.62, which suggests CTXR is a Buy.
                  What is CTXR’s CCI (14)?
                  CTXR’s CCI (14) is -11.22, which suggests CTXR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis